Is NTR a Buy? What to Consider in 2026

Last updated July 2026

Short answer

The bull case for Nutrien (NTR) rests on Potash pricing and record volumes: Potash is Nutrien's highest-margin upstream nutrient, and the company is the world's largest producer. Revenue (TTM) is ~$28 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Whether NTR is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S. dollars. The company runs four segments: Retail (Nutrien Ag Solutions), which distributes crop nutrients, crop protection, seed and services to farmers through a large network of stores across North America, South America and Australia, plus three upstream segments (Potash, Nitrogen and Phosphate) that mine and manufacture the fertilizers themselves. Nutrien is the largest potash producer in the world by capacity and one of the largest nitrogen producers, so its upstream results move directly with global fertilizer benchmarks, while Retail earns more stable margins from proprietary products and services. The investment picture is a blend of commodity cyclicality and defensive scale. When potash and nitrogen prices are firm, as they were through 2025 and into 2026, the upstream segments throw off large cash flows and consolidated earnings jump. When prices fall, upstream profits compress quickly, and the Retail arm plus the dividend become the ballast. Nutrien has leaned into shareholder returns (a growing dividend and share buybacks) and cost discipline, framing itself as a lower-volatility way to own the crop-inputs theme than the pure-play miners or nitrogen producers.

What's the case for buying NTR?

1. Potash pricing and record volumes

Potash is Nutrien's highest-margin upstream nutrient, and the company is the world's largest producer. Through 2025 and into Q1 2026 it delivered record potash sales volumes at higher global benchmark prices, with potash adjusted EBITDA of ~$578 million in Q1 2026 alone. Because Nutrien has low-cost Saskatchewan mines and can flex volume, the potash cycle is the single biggest swing factor in its earnings.

2. Nitrogen leverage to natural gas

Nitrogen fertilizer (ammonia, urea) is made from natural gas, so Nutrien's North American plants benefit from relatively cheap U.S. gas versus European rivals whose costs track higher gas prices. Higher nitrogen selling prices and volumes lifted the segment in 2025, and management is expanding upstream fertilizer volumes from North American plants as a 2026 growth driver.

3. Retail as the steady cash engine

Nutrien Ag Solutions is the largest ag-retail network in the Americas and generates more stable, less commodity-linked margins from proprietary products, seed, crop protection and services. Management guides Retail adjusted EBITDA to ~$1.75 to $1.95 billion for 2026 and treats it as structural growth that smooths the upstream cycle.

4. Capital returns and cost discipline

Nutrien pays a US$2.20 annualized dividend (about a 3% yield) and runs a normal course issuer bid to buy back up to 5% of shares, repurchasing roughly 2% in 2025 for ~$551 million. Alongside cost-savings initiatives in Retail, the capital-return program is a core part of the story for holders who want cash back through the cycle.

What are the risks to NTR?

The dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. Natural gas cost spikes would squeeze nitrogen margins, and weather, crop prices and farmer income drive demand for both fertilizer and Retail products in ways Nutrien cannot control. Geopolitics matters heavily, since sanctions, tariffs and shifts in Russian and Belarusian potash supply move global benchmarks. Foreign-exchange swings (the company operates globally but reports in USD) and heavy capital spending on mines and plants add further variability. Finally, the fertilizer industry is concentrated and has faced antitrust and price-fixing litigation, an overhang for the whole peer group.

How is NTR valued? (as of JULY 2026)

Price

$65.43

Market cap

$31.41B

P/E (TTM)

13.33

Forward P/E

12.50

Price / book

1.25

Beta

1.06

52-week range

$53.03 to $85.36

Snapshot for NTR as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Share price: ~$66
Market cap: ~$32 billion
Revenue (TTM): ~$28 billion
FY2025 net earnings: ~$2.3 billion
FY2025 adjusted EBITDA: ~$6.05 billion
Dividend / yield: ~$2.20 per share (~3.3%)

As of July 2026 NTR trades near $66 for a market cap of roughly $32 billion, at a trailing P/E around 16 and a forward P/E near 15.5, modest multiples typical of a cyclical commodity producer. Q1 2026 revenue was ~$6.0 billion (up ~19% year over year) with adjusted EBITDA of ~$1.11 billion, and the business is seasonal, with the spring planting quarter usually the strongest. Because so much of the profit is commodity-driven, valuation multiples on trailing earnings can look cheap near cycle peaks and expensive near troughs, so context on where fertilizer prices sit matters more than the headline P/E.

How do you decide if NTR is a buy?

Rather than asking whether NTR is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold NTR indirectly through an index or sector ETF before adding more.

For the full picture, see the NTR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about NTR against your real portfolio and see your actual exposure before deciding.

The bottom line on NTR

The bottom line: Nutrien's story right now is Potash pricing and record volumes, with revenue (ttm) at ~$28 billion. If you believe that narrative continues, the call is about sizing NTR sensibly and checking overlap with what you own; if you doubt it (the risk: the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around NTR with Walnut

Use Nutrien as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is NTR a good stock to buy right now?

The case for Nutrien right now is Potash pricing and record volumes, with revenue (ttm) at ~$28 billion. If you believe that thesis holds, NTR is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is the dominant risk is commodity price cyclicality: potash, nitrogen and phosphate prices can fall sharply, and because upstream margins are highly operationally geared, consolidated earnings can drop far faster than revenue. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Nutrien do?

Nutrien is a Canadian-headquartered agricultural giant formed from the 2018 merger of Potash Corp and Agrium, and it reports in U.S.

What are the main risks of NTR?

What does Nutrien actually do?

Nutrien is the world's largest crop-inputs company. It mines and manufactures fertilizer (potash, nitrogen and phosphate) through its upstream segments, and it distributes crop nutrients, crop protection, seed and agronomic services to farmers through Nutrien Ag Solutions, the largest ag-retail network in the Americas.

Is NTR a good investment?

Walnut is not an investment adviser and cannot tell you whether to buy NTR. The bull case is a low-cost global fertilizer leader with a large stable Retail arm, a ~3% dividend and buybacks, trading at modest multiples. The bear case is deep commodity cyclicality: potash and nitrogen prices can fall fast and take earnings with them, and demand depends on weather, crop prices and geopolitics. How you weigh those depends on your own goals and risk tolerance.

Does Nutrien pay a dividend?

Yes. Nutrien pays a US$0.55 quarterly dividend, or US$2.20 annualized, which works out to roughly a 3.3% yield at a mid-2026 share price near $66. The company has generally raised the dividend over time and also buys back stock, returning cash through the commodity cycle.

Why is NTR's stock so tied to fertilizer prices?

Nutrien's upstream Potash, Nitrogen and Phosphate segments sell commodities at global benchmark prices, and their production costs are relatively fixed. That operational leverage means when prices rise, upstream profits jump, and when prices fall, profits compress quickly. The Retail segment is steadier, but the upstream nutrients are the main swing factor in earnings.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell NTR; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.